Sign In
Buy ADMA
$8.69
+0.120 (+1.40%)
At Close: Jun 23, 2026
Does Adma Biologics (ADMA) Have the Potential to Rally 51.75% as Wall Street Analysts Expect?
10:55am, Monday, 07'th Apr 2025
The mean of analysts' price targets for Adma Biologics (ADMA) points to a 51.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among a
ADMA Biologics Statement on Tariffs
07:00am, Monday, 07'th Apr 2025
Reiterates Strategic Advantage Through Fully U.S.-Based Manufacturing Operations, Commercialization and End-Market Sales, and Vertically Integrated U.S.-Based Supply Chain Reiterates Strategic Advanta
Wall Street Analysts See Adma Biologics (ADMA) as a Buy: Should You Invest?
10:31am, Monday, 31'st Mar 2025
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often
Adma Biologics (ADMA) Just Flashed Golden Cross Signal: Do You Buy?
10:55am, Wednesday, 26'th Mar 2025
ADMA Biologics Inc (ADMA) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, ADMA's 50-day simple moving average crossed above i
Here is What to Know Beyond Why ADMA Biologics Inc (ADMA) is a Trending Stock
05:45pm, Friday, 21'st Mar 2025
Adma Biologics (ADMA) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
ADMA Biologics: Premium Valuation Justified By Strong Fundamentals And Future Potential
03:04pm, Friday, 21'st Mar 2025
ADMA Biologics shows robust revenue growth, driven by its innovative IVIG product, ASCENIV, which targets primary humoral immunodeficiency and includes RSV antibodies. Q4 earnings reveal a 59% year-ov
Wall Street Analysts Predict a 39.08% Upside in Adma Biologics (ADMA): Here's What You Should Know
10:55am, Friday, 21'st Mar 2025
The mean of analysts' price targets for Adma Biologics (ADMA) points to a 39.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among a
Adma Biologics (ADMA) Surges 10.2%: Is This an Indication of Further Gains?
10:31am, Thursday, 20'th Mar 2025
Adma Biologics (ADMA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more stre
Recent Price Trend in Adma Biologics (ADMA) is Your Friend, Here's Why
09:52am, Thursday, 20'th Mar 2025
Adma Biologics (ADMA) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it throu
Why Adma Biologics (ADMA) Outpaced the Stock Market Today
06:55pm, Monday, 17'th Mar 2025
In the most recent trading session, Adma Biologics (ADMA) closed at $18.67, indicating a +1.3% shift from the previous trading day.
Will ADMA Biologics Stock Continue Its Momentum in 2025?
10:40am, Friday, 14'th Mar 2025
ADMA continues to maintain momentum in 2025 after its stupendous performance in 2024. Strong demand for Asceniv should fuel growth.
Should You Invest in Adma Biologics (ADMA) Based on Bullish Wall Street Views?
10:36am, Thursday, 13'th Mar 2025
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often
How This Top Small-Cap Growth Fund Wins Big
07:00am, Friday, 07'th Mar 2025
In a stock market that favors the giants, it's still possible to reap big gains investing in Wall Street's small fries. The post How This Top Small-Cap Growth Fund Wins Big appeared first on Investor'
Lost Money on ADMA Biologics, Inc.(ADMA)? You May Have Been Affected by Fraud- Contact Levi & Korsinsky
11:45am, Wednesday, 05'th Mar 2025
NEW YORK, NY / ACCESS Newswire / March 5, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of ADMA Biologics, Inc. ("ADMA Biologics, Inc.") (NASDAQ:ADMA) concerning po
How Much Upside is Left in Adma Biologics (ADMA)? Wall Street Analysts Think 52.85%
10:56am, Wednesday, 05'th Mar 2025
The average of price targets set by Wall Street analysts indicates a potential upside of 52.9% in Adma Biologics (ADMA). While the effectiveness of this highly sought-after metric is questionable, the
